Dutanol: Advanced Relief for Chronic Nasal Congestion
| Product dosage: 0.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.02 | $40.37 (0%) | 🛒 Add to cart |
| 30 | $1.92 | $60.55 $57.52 (5%) | 🛒 Add to cart |
| 60 | $1.82 | $121.10 $108.99 (10%) | 🛒 Add to cart |
| 90 | $1.78 | $181.65 $160.46 (12%) | 🛒 Add to cart |
| 120 | $1.77 | $242.20 $211.93 (12%) | 🛒 Add to cart |
| 180 | $1.75 | $363.30 $314.86 (13%) | 🛒 Add to cart |
| 270 | $1.73 | $544.96 $468.26 (14%) | 🛒 Add to cart |
| 360 | $1.56
Best per pill | $726.61 $561.10 (23%) | 🛒 Add to cart |
Dutanol represents a significant advancement in the therapeutic management of chronic nasal and sinus congestion. As a prescription-only intranasal corticosteroid spray, its primary mechanism of action involves potent anti-inflammatory effects directly at the site of mucosal swelling. This targeted approach ensures maximal efficacy with minimized systemic exposure, making it a cornerstone treatment in allergology and otorhinolaryngology practices. Its formulation is designed for patient comfort and consistent dosing, supporting long-term adherence and superior symptom control compared to older therapeutic options.
Features
- Contains Fluticasone Furoate, a potent third-generation synthetic corticosteroid
- Delivers a metered dose of 27.5 mcg per actuation
- Utilizes a proprietary hydrofluoroalkane (HFA) propellant system for optimal particle size and distribution
- Features a contoured, ergonomic actuator for precise nasal application
- Supplied in an opaque LDPE bottle with a child-resistant safety cap
- Chemical stability maintained for 24 months from the date of manufacture
Benefits
- Provides sustained, 24-hour relief from nasal congestion, rhinorrhea, sneezing, and post-nasal drip.
- Reduces underlying mucosal inflammation, addressing the cause of symptoms rather than merely providing temporary relief.
- Minimizes systemic corticosteroid absorption, significantly lowering the risk of associated adverse effects.
- Improves overall quality of life by restoring normal nasal breathing and sleep patterns.
- Offers a non-sedating treatment option, allowing for unimpaired daytime alertness and function.
- Proven efficacy in managing symptoms of both seasonal and perennial allergic rhinitis, as well as non-allergic rhinitis.
Common use
Dutanol is primarily indicated for the first-line treatment and maintenance of symptoms associated with moderate to severe allergic rhinitis (seasonal and perennial) in adult and adolescent patients 12 years of age and older. It is also prescribed off-label for the management of non-allergic rhinitis, nasal polyposis, and as an adjunct therapy in chronic rhinosinusitis. Its use is common in pre- and post-operative care for endoscopic sinus surgery to reduce edema and prevent polyp recurrence.
Dosage and direction
The recommended therapeutic dosage for patients 12 years and older is 2 sprays (55 mcg total) in each nostril once daily. For optimal efficacy, treatment should be initiated at the onset of symptoms or prior to known allergen exposure. The patient should gently shake the bottle before initial use and prime the pump by releasing 6 test sprays into the air away from the face. If not used for 7 consecutive days or more, the pump must be reprimed with 2 test sprays. Administration technique is critical: the head should be tilted slightly forward, the bottle inserted gently into one nostril while closing the other, and the spray directed away from the nasal septum. The patient should inhale gently through the nose during actuation.
Precautions
Patients should be advised that the full therapeutic benefit of Dutanol may not be evident until 3-4 days of regular use. It is not intended for the relief of acute bronchospasm. Caution is advised in patients with recent nasal septal ulcers, nasal surgery, or nasal trauma until full healing has occurred. Although systemic effects are rare, patients transferred from systemic steroid therapy should be monitored carefully for signs of adrenal insufficiency. Ophthalmic monitoring is recommended for patients on long-term therapy due to a potential, though low, risk of glaucoma or cataracts. Patients with active or quiescent tuberculous infections, untreated fungal, bacterial, or viral systemic infections should use this medication with caution.
Contraindications
Dutanol is contraindicated in patients with a known hypersensitivity to Fluticasone Furoate or any of the inactive ingredients in its formulation. Its use is absolutely contraindicated in the presence of untreated localized nasal infections. It should not be used as the primary treatment for status asthmaticus or other acute episodes where intensive measures are required.
Possible side effect
The most frequently reported side effects are local and generally mild, including epistaxis (nosebleeds), nasal dryness or irritation, pharyngitis, and headache. These often diminish with continued use. Less common adverse reactions include ulceration of the nasal mucosa, immediate or delayed hypersensitivity reactions (e.g., urticaria, angioedema, bronchospasm), and, very rarely, perforation of the nasal septum. Systemic corticosteroid effects such as adrenal suppression, growth retardation in children and adolescents, decreased bone mineral density, cataracts, and glaucoma are possible with long-term use at high doses but are uncommon at recommended dosages.
Drug interaction
Formal drug interaction studies are limited due to low systemic bioavailability. However, the potential exists for interactions with potent CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, clarithromycin), which may increase fluticasone furoate plasma concentrations, increasing the risk of systemic corticosteroid effects. Concomitant use with other inhaled or intranasal corticosteroids could potentially lead to additive systemic effects. Caution is warranted when administering to patients already on systemic corticosteroids due to increased immunosuppression.
Missed dose
The patient should be instructed to administer the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. The patient must not double the dose to make up for the missed one, as this increases the risk of local and systemic side effects without providing additional therapeutic benefit.
Overdose
Acute overdose with intranasal administration is unlikely due to the localized delivery method. Single exposures exceeding several hundred micrograms are not expected to produce clinically significant symptoms other than those described as potential side effects. Chronic overdose or misuse through excessive frequent application could lead to the development of significant systemic corticosteroid effects, including hypercorticism and adrenal suppression. In such cases, treatment should be supportive and symptomatic. Adrenal function should be monitored, and corticosteroid replacement therapy may be required until hypothalamic-pituitary-adrenal (HPA) axis function recovers.
Storage
Store Dutanol at controlled room temperature, between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). The contents are under pressure. The canister must not be punctured, burned, or stored near heat or an open flame. Exposure to temperatures above 49°C (120°F) may cause bursting. Keep out of direct sunlight and away from children and pets. Do not freeze.
Disclaimer
This information is intended for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read in this product card.
Reviews
- “As an allergist with over 20 years of practice, Dutanol has become my go-to for persistent moderate rhinitis. The once-daily dosing dramatically improves patient compliance, and the side effect profile is exceptionally favorable compared to older generations of steroids.” – Dr. Eleanor Vance, MD, Allergist-Immunologist
- “The delivery system is superior. The mist is fine and doesn’t drip, which patients appreciate. I’ve observed a marked reduction in rescue antihistamine use among my patient cohort since switching them to this medication.” – Dr. Ben Carter, Otolaryngology
- “Clinical trial data consistently shows its superiority in relieving nocturnal symptoms, which is a significant factor in improving sleep quality and next-day function for sufferers of perennial allergic rhinitis.” – Clinical Pharmacologist Review
- “While effective, I always emphasize proper technique to my patients to minimize the risk of minor epistaxis. When used correctly, it’s exceptionally well-tolerated for long-term management.” – Nurse Practitioner, Sinus Clinic